Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Ovintiv Inc. (DE) (OVV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Ovintiv Inc. (DE) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.28 (market cap $12.58B), while Ovintiv Inc. (DE) trades at $64.22 (market cap $17.53B). The key difference: Ovintiv Inc. (DE) is the larger of the two by market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Ovintiv Inc. (DE) for 1 Days on average.
| HALO | OVV | |
|---|---|---|
Market Cap | $12.58B | $17.53B |
Volume | 2,179,278 | 3,002,714 |
Sector | Health | Energy |
52-Week High | $115.22 | $66.97 |
52-Week Low | $61.63 | $35.97 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $21.86B |
Dividend Yield | — | 1.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Ovintiv Inc. (DE)
Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →
